Literature DB >> 6610440

Thymus-derived lymphocyte enumeration in patients with uveal malignant melanoma.

N T Felberg, J A Shields.   

Abstract

Thymus-derived lymphocytes (T lymphocytes) were enumerated in patients with uveal malignant melanoma. Two T-lymphocyte subpopulations were determined, the active rosette forming cells (A-RFC) and the total rosette forming cells (T-RFC). Subjects were divided into the following groups: (a) pretreatment patients, (b) patients treated by enucleation, (c) patients treated by photocoagulation, (d) patients treated by cobalt plaque radiotherapy, (e) patients treated by enucleation who developed clinically detectable metastasis, and (f) normal controls. There were no differences in the numbers of A-RFC or T-RFC in the control population, pretreatment patients, and those treated in the different ways. Statistically significant depressions of A-RFC and T-RFC levels were seen in patients with metastatic lesions, suggesting that they had an impairment of immunocompetence, as measured by T-lymphocyte rosette formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610440      PMCID: PMC1040387          DOI: 10.1136/bjo.68.7.486

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Immunological mechanisms in choroidal melanoma.

Authors:  D H Char
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

2.  Soluble membrane antigens of human malignant melanoma cells.

Authors:  A C Hollinshead; R B Herberman; W J Jaffurs; L K Alpert; J P Minton; J E Harris
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Immune responsiveness in patients with choroidal malignant melanoma.

Authors:  I A Priluck; D M Robertson; D J Pritchard; D M Ilstrup
Journal:  Am J Ophthalmol       Date:  1979-02       Impact factor: 5.258

5.  Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck.

Authors:  M J Deegan; S W Coulthard
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

Review 6.  Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.

Authors:  L E Zimmerman; I W McLean; W D Foster
Journal:  Br J Ophthalmol       Date:  1978-06       Impact factor: 4.638

7.  The active E-rosette test: a sensitive in vitro correlate for human delayed-type hypersensitivity.

Authors:  P J Felsburg; R Edelman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  "No-touch" cryosurgical enucleation: a minimal trauma technique for eyes harboring intraocular malignancy.

Authors:  R S Wilson; F T Fraunfelder
Journal:  Ophthalmology       Date:  1978-11       Impact factor: 12.079

9.  Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.

Authors:  Z Fuks; S Strober; H S Kaplan
Journal:  N Engl J Med       Date:  1976-12-02       Impact factor: 91.245

10.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.